v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Oct. 31, 2014
Oct. 31, 2013
Cash flows from operating activities:    
Net income $ 8,795 $ 5,950
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 4,187 3,140
Loss on revaluation of redeemable convertible preferred stock derivative 735 109
Imputed interest on notes payable 0 30
Deferred taxes 2,026 3,670
Stock-based compensation 793 44
Changes in operating assets and liabilities:    
Restricted cash 0 791
Accounts receivable (349) (186)
Inventories (365) (204)
Prepaid expenses (2,124) (230)
Accounts payable (1,542) (533)
Due to trust 0 (791)
Accrued compensation (1,125) (555)
Accrued liabilities (540) 1,080
Income taxes payable 0 (77)
Deferred rent 88 199
Net cash provided by operating activities 10,579 12,437
Cash flows from investing activities:    
Purchase of property and equipment (1,477) (1,226)
Purchase of software and capitalized software development costs (4,851) (2,735)
Purchase of other investments (305) 0
Net cash used in investing activities (6,633) (3,961)
Cash flows from financing activities:    
Repayment of notes payable 0 (1,500)
Dividend payments (50,347) 0
Proceeds from initial public offering, net of payments for offering costs 132,587 0
Proceeds from exercise of common stock options 2,397 232
Proceeds from exercise of common stock warrants 2,380 17
Tax benefit from exercise of common stock options 2,974 0
Net cash provided by (used in) financing activities 89,991 (1,251)
Increase in cash and cash equivalents 93,937 7,225
Beginning cash and cash equivalents 13,917 5,905
Ending cash and cash equivalents 107,854 13,130
Supplemental disclosures of non-cash investing and financing activities:    
Conversion of preferred stock to common stock 50,822 0
Preferred stock accretion 4,021 925
Reclassification of series D-3 redeemable convertible preferred stock derivative liability 6,917 0
Common stock warrants exercised 2,334 35
Series D-3 redeemable convertible preferred stock dividend $ 0 $ 519